Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

× No keyword cloud information.

14 in total

1. Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?"

Authors: Morgan H James; Gary Aston-Jones
Journal: Brain Res Date: 2020-01-10 Impact factor: 3.252

Review 2. Sleep-mediated regulation of reward circuits: implications in substance use disorders.

Authors: Rong Guo; Dylan Thomas Vaughan; Ana Lourdes Almeida Rojo; Yanhua H Huang
Journal: Neuropsychopharmacology Date: 2022-06-16 Impact factor: 7.853

Review 3. New directions in modelling dysregulated reward seeking for food and drugs.

Authors: Robyn M Brown; Christopher V Dayas; Morgan H James; Rachel J Smith
Journal: Neurosci Biobehav Rev Date: 2021-11-02 Impact factor: 8.989

Review 4. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors: Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal: Neuropharmacology Date: 2020-10-19 Impact factor: 5.250

Review 5. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors: Reda M Chalhoub; Peter W Kalivas
Journal: Drugs Date: 2020-10 Impact factor: 9.546

6. The sensation seeking trait confers a dormant susceptibility to addiction that is revealed by intermittent cocaine self-administration in rats.

Authors: Shayna L O'Connor; Gary Aston-Jones; Morgan H James
Journal: Neuropharmacology Date: 2021-04-20 Impact factor: 5.273

Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

1. Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?"

Review 2. Sleep-mediated regulation of reward circuits: implications in substance use disorders.

Review 3. New directions in modelling dysregulated reward seeking for food and drugs.

Review 4. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Review 5. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

6. The sensation seeking trait confers a dormant susceptibility to addiction that is revealed by intermittent cocaine self-administration in rats.

7. Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior.

Review 8. At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities.

9. Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.

Review 10. Targeting the Orexin System for Prescription Opioid Use Disorder.